SAEYY OTC
Redcare Pharmacy N.V.
1W: +18.8%
1M: +12.9%
3M: +8.6%
YTD: +5.5%
1Y: -4.7%
3Y: -20.2%
5Y: -59.2%
$8.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.2B
+24.2% ▲
5Y CAGR: +18.3%
Total Liabilities
$767M
+55.5% ▲
5Y CAGR: +47.0%
Shareholders Equity
$459M
-5.2% ▼
5Y CAGR: +1.5%
Cash & Investments
$203M
+14.6% ▲
5Y CAGR: +9.7%
Total Debt
$415M
+68.5% ▲
5Y CAGR: +61.1%
Net Debt
$323M
+115.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $247M | $66M | $84M | $97M | $92M |
| Short-Term Investments | $36M | $118M | $120M | $81M | $111M |
| Cash & ST Investments | $283M | $184M | $204M | $178M | $203M |
| Net Receivables | $41M | $44M | $103M | $110M | $153M |
| Inventory | $97M | $100M | $136M | $154M | $214M |
| Other Current Assets | $21M | $28M | $46M | $41M | $32M |
| Total Current Assets | $433M | $344M | $500M | $500M | $619M |
| Property, Plant & Equip. | $78M | $85M | $87M | $83M | $191M |
| Goodwill & Intangibles | $257M | $289M | $428M | $411M | $393M |
| Long-Term Investments | -$22M | -$107M | $1M | $1M | $9M |
| Other Non-Current Assets | $2K | $118M | $3M | $8M | $0 |
| Total Non-Current Assets | $350M | $386M | $522M | $503M | $627M |
| Total Assets | $783M | $729M | $1.0B | $1.0B | $1.2B |
| — Liabilities — | |||||
| Accounts Payable | $78M | $69M | $152M | $175M | $248M |
| Short-Term Debt | $2M | $2M | $2M | $2M | $86M |
| Deferred Revenue | $33M | $35M | $573K | $0 | $0 |
| Other Current Liabilities | $28M | $4M | $6M | $9M | $53M |
| Total Current Liabilities | $124M | $119M | $224M | $250M | $400M |
| Long-Term Debt | $204M | $220M | $205M | $209M | $262M |
| Other Non-Current Liab. | $14M | $8M | $62M | $2M | $1M |
| Total Non-Current Liabilities | $244M | $256M | $305M | $244M | $367M |
| Total Liabilities | $368M | $375M | $470M | $493M | $767M |
| — Equity — | |||||
| Common Stock | $361K | $362K | $398K | $402K | $400K |
| Retained Earnings | -$208M | -$285M | -$279M | -$324M | -$358M |
| Accumulated OCI | $56M | $69M | $36M | $53M | $61M |
| Total Stockholders Equity | $415M | $355M | $522M | $484M | $459M |
| Total Liabilities & Equity | $783M | $729M | $1.0B | $1.0B | $1.2B |
| — Key Metrics — | |||||
| Total Debt | $236M | $255M | $245M | $247M | $415M |
| Net Debt | -$11M | $189M | $161M | $150M | $323M |
| Total Investments | $15M | $11M | $121M | $82M | $120M |